Código QR (código de barras bidimensional)

Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain

Abstract Background Respiratory syncytial virus (RSV) is associated with substantial morbidity among infants. This study modelled the potential public health and economic impact of nirsevimab, a long-acting monoclonal antibody, as an immunoprophylactic strategy for all infants in Spain in their firs...

Fuld beskrivelse

Na minha lista:
Principais autores: Ruth Gil-Prieto, Jaime Jesus Pérez, Georgina Drago, Alexia Kieffer, Julie Roïz, Paulina Kazmierska, Aditya Sardesai, Solène de Boisvilliers, Juan Luis López-Belmonte, Matthieu Beuvelet, Javier Alvarez Aldean
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2024-09-01
Serier:BMC Infectious Diseases
Fag:
Hospitalisation
Immunisation
Infant
Nirsevimab
Public health
Respiratory syncytial viruses
Online adgang:https://doi.org/10.1186/s12879-024-09642-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker